Complement C1s and C4d as prognostic biomarkers in renal cancer: emergence of non-canonical functions of C1s - Archive ouverte HAL Access content directly
Journal Articles Cancer Immunology Research Year : 2021

Complement C1s and C4d as prognostic biomarkers in renal cancer: emergence of non-canonical functions of C1s

Jules Russick
Maxime Meylan
Pierre Validire
  • Function : Author
Lubka T Roumenina
  • Function : Author
  • PersonId : 971707

Abstract

The complement system plays a complex role in cancer. In clear cell renal cell carcinoma (ccRCC), local production of complement proteins drives tumor progression, but the mechanisms by which they do this are poorly understood. We found that complement activation, as reflected by high plasma C4d or as C4d deposits at the tumor site, was associated with poor prognosis in two cohorts of patients with ccRCC. High expression of the C4-activating enzyme C1s by tumor cells was associated with poor prognosis in three cohorts. Multivariate Cox analysis revealed that the prognostic value of C1s was independent from complement deposits, suggesting the possibility of complement cascade-unrelated, protumoral functions for C1s. Silencing of C1s in cancer cell lines resulted in decreased proliferation and viability of the cells and in increased activation of T cells in in vitro cocultures. Tumors expressing high levels of C1s showed high infiltration of macrophages and T cells. Modification of the tumor cell phenotype and T-cell activation were independent of extracellular C1s levels, suggesting that C1s was acting in an intracellular, noncanonical manner. In conclusion, our data point to C1s playing a dual role in promoting ccRCC progression by triggering complement activation and by modulating the tumor cell phenotype and tumor microenvironment in a complement cascade-independent, noncanonical manner. Overexpression of C1s by tumor cells could be a new escape mechanism to promote tumor progression
Fichier principal
Vignette du fichier
Daugan et al C1s.pdf (14.77 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03241408 , version 1 (28-05-2021)

Identifiers

Cite

Marie V Daugan, Margot Revel, Jules Russick, Marie-Agnes Dragon-Durey, Christine Gaboriaud, et al.. Complement C1s and C4d as prognostic biomarkers in renal cancer: emergence of non-canonical functions of C1s. Cancer Immunology Research, 2021, 9 (8), pp.891-908. ⟨10.1158/2326-6066.cir-20-0532⟩. ⟨hal-03241408⟩
104 View
434 Download

Altmetric

Share

Gmail Facebook X LinkedIn More